4basebio PLC (AIM: 4BB)
London
· Delayed Price · Currency is GBP · Price in GBX1,176.00
-9.00 (-0.76%)
Dec 30, 2024, 8:03 AM GMT+1
4basebio Market Cap
4basebio has a market cap or net worth of 154.94 million as of December 30, 2024. Its market cap has increased by 96.52% in one year.
Market Cap
154.94M
Enterprise Value
167.72M
Revenue
596.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1,176.00
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 41.57M to 154.94M, an increase of 272.71%. That is a compound annual growth rate of 40.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2024 | 154.94M | 84.96% |
| Dec 29, 2023 | 83.77M | -4.21% |
| Dec 30, 2022 | 87.45M | 15.45% |
| Dec 31, 2021 | 75.75M | 82.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 162.16B |
| GSK plc | 54.78B |
| Haleon | 34.28B |
| Smith & Nephew | 8.57B |
| ConvaTec Group | 4.52B |
| Hikma Pharmaceuticals | 4.40B |
| HUTCHMED (China) | 1.98B |
| Indivior | 1.26B |